Institutional investors purchased a net $5.7 million shares of INCY during the quarter ended December 2012 and now own 114.15% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
| Mutual fund holders | 72.44% |
| Other institutional | 41.71% |
| Individual stakeholders | 15.57% |